Clinical Trials Browser

Adenocarcinoma of Lung, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Intestinal Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07325214 2026-01-12

Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer

Phase NA Not yet recruiting

136 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07272109 2025-12-15

PTCA199-16

Phase 3 Not yet recruiting

210 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07262567 2025-12-03

Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer

Phase 3 Not yet recruiting

320 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT06755359 2025-12-02

Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer

Phase NA Not yet recruiting

40 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT06177522 2025-11-18

Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer

Phase 2 Not yet recruiting

30 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07208539 2025-10-06

ZSPAC-14

Phase 2 Not yet recruiting

77 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07175389 2025-09-16

JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure

Phase 1/2 Not yet recruiting

10 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07172503 2025-09-15

Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors

Phase NA Not yet recruiting

56 enrolled

Gastrointestinal

Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT07160283 2025-09-08

The Efficacy and Safety of Trilaciclib in Bone Marrow Protection Before Chemotherapy for Advanced Bile Duct Cancer and Pancreatic Cancer

Phase 2 Not yet recruiting

96 enrolled

Gastrointestinal

Biliary Tract Neoplasms, Pancreatic Neoplasms

NCT07153289 2025-09-03

ResCPa

Phase 1/2 Not yet recruiting

38 enrolled

Gastrointestinal

Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal

NCT07132060 2025-08-27

MRI-guided Dose Intensification Program Locally Advanced Pancreatic Cancer

Phase NA Not yet recruiting

30 enrolled

Gastrointestinal

Pancreatic Neoplasms

Clinical Trials

Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy

64Cu-DOTA A2 scFv-Fc2 DM With Positron Emission Tomography for the Imaging of Patients With Locally Advanced or Metastatic PSCA-Expressing Pancreatic Cancer

BRIDGE-8

Phase 1/2 Study TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer

BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion

SUNRISE

A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors

A Study Comparing MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Cancer

An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With Pancreatic Cancer

ODI-2001-01

PANACEA

NUMANTIA-2

Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors

ChefHat-001

ResQ108B-PANC

E-FACTOR

A Prospective Non-randomized Controlled Interventional Study on the Effect of Shouhui Tongbian Capsules Combined With Pancreatin Enteric-coated Capsules on Pancreatic Exocrine Function in Patients After Curative Resection for Pancreatic Cancer

Chimeric Antigen Receptor Macrophages Targeting c-MET for Advanced Stage of Pancreatic Cancer Patients

e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients

A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer

Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer

ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing Screening

SURGIMEDIA

PRE-PDAC

Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

HY-PANC

PRISM-TAMP

Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer

WATCH AND ACT

PAN-CLO-BU

IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer

Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer

Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer

Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC)

A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive Pancreatic Cancer

FAST

SL-28 for Advanced Solid Tumours

Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer

PTCA199-16

Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer

Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer

Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer

ZSPAC-14

JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure

Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors

The Efficacy and Safety of Trilaciclib in Bone Marrow Protection Before Chemotherapy for Advanced Bile Duct Cancer and Pancreatic Cancer

ResCPa

MRI-guided Dose Intensification Program Locally Advanced Pancreatic Cancer